These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 1865740)
21. [Binding of serum immunoglobulins to human inner ear tissue in inner ear hearing loss: methodologic limits]. Gebbers JO; Altermatt HJ; Arnold W; Laissue JA; Pfaltz CR HNO; 1987 Dec; 35(12):487-91. PubMed ID: 3323147 [TBL] [Abstract][Full Text] [Related]
22. Immune-mediated inner ear disease. Bovo R; Aimoni C; Martini A Acta Otolaryngol; 2006 Oct; 126(10):1012-21. PubMed ID: 16923703 [TBL] [Abstract][Full Text] [Related]
23. [Audiological test results of the autoimmune sensorineural hearing loss]. Gu R; Zou J; Yu L Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(1):20-3. PubMed ID: 7598979 [TBL] [Abstract][Full Text] [Related]
29. Autoimmunity and otologic disease: clinical and experimental aspects. Barna BP; Hughes GB Clin Lab Med; 1988 Jun; 8(2):385-98. PubMed ID: 3284702 [TBL] [Abstract][Full Text] [Related]
30. [Acute autoimmune sensorineural hearing loss in pregnant women with Leśniowski-Crohn disease]. Kuczkowski J; Kozłowski J; Narozny W Otolaryngol Pol; 2006; 60(4):583-5. PubMed ID: 17152813 [TBL] [Abstract][Full Text] [Related]
31. Autoimmune sensorineural hearing loss in young patients: an exploratory study. Tomasi JP; Lona A; Deggouj N; Gersdorff M Laryngoscope; 2001 Nov; 111(11 Pt 1):2050-3. PubMed ID: 11801995 [TBL] [Abstract][Full Text] [Related]
32. Type II collagen-induced autoimmune ear disease in mice: a preliminary report on an epitope of the type II collagen molecule that induced inner ear lesions. Takeda T; Sudo N; Kitano H; Yoo TJ Am J Otol; 1996 Jan; 17(1):69-75. PubMed ID: 8694137 [TBL] [Abstract][Full Text] [Related]
33. [Diagnosis and treatment of sensorineural hearing deficits of autoimmune origin]. Castillo JL; López-Escámez JA Acta Otorrinolaringol Esp; 2000; 51(5):433-6. PubMed ID: 11000687 [TBL] [Abstract][Full Text] [Related]
34. Autoimmune identification of sudden hearing loss. García Callejo FJ; Marco Algarra J; Martínez Beneyto MP; Orts Alborch MH; Morant Ventura A Acta Otolaryngol; 2003 Jan; 123(2):168-71. PubMed ID: 12701734 [TBL] [Abstract][Full Text] [Related]
36. Clinical evaluation and treatment of immune-mediated inner ear disease. Welling DB Ear Nose Throat J; 1996 May; 75(5):301-5. PubMed ID: 8935529 [TBL] [Abstract][Full Text] [Related]
37. ELISPOT determination of interferon-gamma T-cell frequencies in patients with autoimmune sensorineural hearing loss. Solares CA; Tuohy VK Methods Mol Biol; 2005; 302():253-60. PubMed ID: 15937357 [TBL] [Abstract][Full Text] [Related]
38. [Progressive inner ear diseases--sequelae of a secondary autoimmune process? Significance of antibodies to endoplasmic reticulum]. Zanetti F; Klein R; Berg PA HNO; 1987 Jan; 35(1):34-7. PubMed ID: 3549636 [TBL] [Abstract][Full Text] [Related]
39. Characteristics of sensorineural hearing loss in children with inner ear anomalies. Coticchia JM; Gokhale A; Waltonen J; Sumer B Am J Otolaryngol; 2006; 27(1):33-8. PubMed ID: 16360821 [TBL] [Abstract][Full Text] [Related]
40. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]